NRG TRANSSEPTAL NEEDLE

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,litera report with the FDA on 2018-07-26 for NRG TRANSSEPTAL NEEDLE manufactured by Baylis Medical Company Inc..

Event Text Entries

[115226385] The reported patient complication is an inherent risk to this type of procedure. There is no evidence to suggest the baylis medical devices caused or contributed to the reported complications. However, as the baylis devices were among the several devices used in the procedures, baylis medical has decided to submit this report.
Patient Sequence No: 1, Text Type: N, H10


[115226386] During a periodic review of published literature by the manufacturer, baylis medical devices were identified among several other manufacturers' devices as having been used in procedures with reported complications. Article reference: pedersen m, leo m, kalla m, et al. Management of tamponade complicating catheter ablation for atrial fibrillation: early removal of pericardial drains is safe and effective and reduces analgesic requirements and hospital stay compared to conventional delayed removal. Jacc: clinical electrophysiology (2017); 3(4): 367-373. As per the article, "the authors performed a retrospective descriptive analysis of 43 cases of tamponade complicating afca from 2006 to 2015, comparing patients in whom the drain was removed early (group early removal (er); n 1/4 25) versus traditional delayed removal (group delayed removal [dr]; n 1/4 18)... Venous access was obtained via the femoral veins and a multipolar catheter placed in the coronary sinus (cs). In cases performed under general anesthesia, all transseptal punctures were carried out under transesophageal guidance. In cases carried out under sedation, 1 case was done with intracardiac echocardiography (ice probe, siemens, munich, germany) for transseptal puncture guidance, 1 was via a patent foramen ovale (pfo)/atrial septic defect (asd) and the remaining case was done with fluoroscopic guidance only. The punctures were done using either the brockenbrough (medtronic, inc. , minneapolis, minnesota), endrys (cook medical, bloomington, indiana) or the nrg rf (baylis medical, montreal, quebec, canada) transseptal needle through a long introducer sheath, usually the mullens (cook medical) or a sheath of the fast-cath transseptal guiding introducer sl series (st. Jude medical, austin, texas). At the operator's preference, either a second separate transseptal puncture was done or the ablation catheter was passed through a second sheath, usually an agilis (agilis nxt steerable introducer, st. Jude medical), and fed across the same initial puncture. "
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number9710452-2018-00030
MDR Report Key7724552
Report SourceCOMPANY REPRESENTATIVE,LITERA
Date Received2018-07-26
Date of Report2018-07-26
Date Mfgr Received2018-06-28
Date Added to Maude2018-07-26
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactDR. MEGHAL KHAKHAR
Manufacturer Street2775 MATHESON BLVD. EEAST
Manufacturer CityMISSISSAUGA, ONTARIO L4W 4P7
Manufacturer CountryCA
Manufacturer PostalL4W 4P7
Manufacturer G1BAYLIS MEDICAL COMPANY INC.
Manufacturer Street2775 MATHESON BLVD. EAST
Manufacturer CityMISSISSAUGA, ONTARIO L4W 4P7
Manufacturer CountryCA
Manufacturer Postal CodeL4W 4P7
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameNRG TRANSSEPTAL NEEDLE
Generic NameRF TRANSSEPTAL NEEDLE
Product CodeDXF
Date Received2018-07-26
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerBAYLIS MEDICAL COMPANY INC.
Manufacturer Address5959 TRANS-CANADA HIGHWAY MONTREAL, QUEBEC H4T 1A1 CA H4T 1A1


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2018-07-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.